The American Diabetes Association, together with the guidelines of the European Society of Cardiology and the European Association for the Study of Diabetes, recommends the periodic use of the glycated hemoglobin (HbA1c) test as an effective tool for early screening and diagnosis of diabetes and prediabetes in healthy individuals.
In line with these recommendations, we are proud to launch a dedicated screening initiative in collaboration with DAY1. This program aims to promote awareness, prevention, and early detection—key elements in supporting the long-term health and well‑being of our people.